• Study on Painful Thumb Osteoarthritis: Comparing Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy for Patients with Inflammatory Thumb Joint Pain

    Recruiting

    3 1 1
    Investigated diseases:
    Norway
  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Italy
  • Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

    Recruiting

    2 1 1 1
    Investigated drugs:
    Denmark Norway Sweden
  • Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +10
  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Poland
  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study on Reducing Immunosuppressive Drugs in Adults with Psoriatic Arthritis: Methotrexate Disodium, Abatacept, and Certolizumab Pegol

    Recruiting

    3 1 1 1
    Investigated diseases:
    Germany Italy
  • Study of Abemaciclib and Letrozole for Patients with Estrogen Receptor Positive Low-Grade Serous Ovarian Cancer and Adult-Type Granulosa Cell Tumor

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France The Netherlands
  • Study on Prednisolone for Women with Unexplained Recurrent Miscarriages

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by